JP2004509845A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509845A5
JP2004509845A5 JP2002500833A JP2002500833A JP2004509845A5 JP 2004509845 A5 JP2004509845 A5 JP 2004509845A5 JP 2002500833 A JP2002500833 A JP 2002500833A JP 2002500833 A JP2002500833 A JP 2002500833A JP 2004509845 A5 JP2004509845 A5 JP 2004509845A5
Authority
JP
Japan
Prior art keywords
linker
analogue
spermine
derivative according
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002500833A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004509845A (ja
Filing date
Publication date
Priority claimed from US09/584,175 external-priority patent/US6646149B1/en
Application filed filed Critical
Publication of JP2004509845A publication Critical patent/JP2004509845A/ja
Publication of JP2004509845A5 publication Critical patent/JP2004509845A5/ja
Pending legal-status Critical Current

Links

JP2002500833A 2000-05-31 2001-05-31 治療剤及び診断剤としての新規ポリアミン類似体 Pending JP2004509845A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/584,175 US6646149B1 (en) 1997-07-15 2000-05-31 Polyamine analogues as therapeutic and diagnostic agents
PCT/US2001/017795 WO2001092218A2 (en) 2000-05-31 2001-05-31 Polyamine analogues as therapeutic and diagnostic agents

Publications (2)

Publication Number Publication Date
JP2004509845A JP2004509845A (ja) 2004-04-02
JP2004509845A5 true JP2004509845A5 (enExample) 2005-04-21

Family

ID=24336202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002500833A Pending JP2004509845A (ja) 2000-05-31 2001-05-31 治療剤及び診断剤としての新規ポリアミン類似体

Country Status (8)

Country Link
US (1) US6646149B1 (enExample)
EP (1) EP1317424A2 (enExample)
JP (1) JP2004509845A (enExample)
KR (1) KR100851452B1 (enExample)
CN (1) CN1512982A (enExample)
AU (1) AU2001268139A1 (enExample)
CA (1) CA2410935A1 (enExample)
WO (1) WO2001092218A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038105A2 (en) * 2000-11-08 2002-05-16 Slil Biomedical Corporation Novel polyamine analog-amino acid conjugates useful as anticancer agents
EP1088815A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonyl amino acid derivatives
RU2003124640A (ru) * 2001-01-08 2005-02-27 Медиквест Терапевтикс, Инк. (Us) Гидрофобные полиаминные аналоги и способы их применения
US7144920B2 (en) 2002-09-23 2006-12-05 Mediquest Therapeutics, Inc. Polyamine analogs that activate antizyme frameshifting
US20070088081A1 (en) * 2002-09-27 2007-04-19 Research Foundation Of The University Of Central Florida Incorporated Polyamine conjugates as selective NMDA inhibitors and anti-cancer drugs
GB0223563D0 (en) * 2002-10-10 2002-11-20 Secr Defence Detection system
JP2007526769A (ja) * 2004-02-19 2007-09-20 エフ2ジー リミテッド 2031オキシドレダクターゼ
GB2414477A (en) * 2004-05-25 2005-11-30 Hunter Fleming Ltd Novel polyamines and their therapeutic use
AU2005251455B2 (en) * 2004-06-14 2008-09-25 Unilever Plc Method of decreasing sebum production and pore size
US7199267B1 (en) * 2005-10-21 2007-04-03 Mediquest Therapeutics, Inc. Recognition of oligiosaccaride molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases
US7411002B2 (en) * 2006-06-07 2008-08-12 The University Of Kansas Polycationic sulfonamides and use thereof
US8779195B2 (en) * 2006-11-15 2014-07-15 Nihon University Polyamine derivatives
WO2008105441A1 (ja) * 2007-02-27 2008-09-04 Ajinomoto Co., Inc. リン吸収抑制活性を有するポリアミノ酸化合物及びリン吸収抑制剤
CN104892449B (zh) * 2014-03-06 2017-06-13 天津红日药业股份有限公司 一种精胺类似物及其药用盐的制备方法和用途
US20170273926A1 (en) * 2016-03-24 2017-09-28 Orbus Therapeutics, Inc. Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers, including gliomas
HRP20201844T1 (hr) 2016-03-25 2021-04-02 Aminex Therapeutics, Inc. Biodostupni poliamini
NZ752894A (en) 2016-10-06 2023-05-26 Orbus Therapeutics Inc Formulations for administration of eflornithine
EP4221698A1 (en) 2020-09-30 2023-08-09 Aminex Therapeutics, Inc. Combination drug substance of polyamine transport inhibitor and dfmo

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309442A (en) 1977-07-11 1982-01-05 Merrell Toraude Et Compagnie Method for controlling fertility in mammals
US4590288A (en) * 1983-06-29 1986-05-20 Exxon Research And Engineering Co. Bi- or polymetallic coordination complex
HU200093B (en) 1983-12-20 1990-04-28 Adam Kovacs Process for production of medical compositions against tumour
EP0187332B1 (en) * 1985-01-10 1989-02-01 Molecular Diagnostics, Inc. Photochemical method of labelling nucleic acids for detection in hybridization assays
US4818770A (en) 1986-10-22 1989-04-04 Boyce Thompson Institute For Plant Research Prevention of a plant disease by specific inhibition of fungal polyamine biosynthesis
US5342945A (en) 1986-12-02 1994-08-30 University Of Florida Research Foundation, Inc. Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US4774339A (en) 1987-08-10 1988-09-27 Molecular Probes, Inc. Chemically reactive dipyrrometheneboron difluoride dyes
US5433896A (en) 1994-05-20 1995-07-18 Molecular Probes, Inc. Dibenzopyrrometheneboron difluoride dyes
US5274113A (en) 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5248782A (en) 1990-12-18 1993-09-28 Molecular Probes, Inc. Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
US5312928A (en) 1991-02-11 1994-05-17 Cambridge Neuroscience Calcium channel antagonists and methodology for their identification
US5187288A (en) 1991-05-22 1993-02-16 Molecular Probes, Inc. Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
PT743853E (pt) 1994-02-08 2001-10-31 Nps Pharma Inc Compostos activos num novo local em canis de calcio activados por um receptor uteis para o tratamento de perturbacoes e doencas neurologicas
WO1996022962A1 (en) 1995-01-23 1996-08-01 The Trustees Of Columbia University In The City Of New York Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
US5583239A (en) 1995-05-30 1996-12-10 Lehigh University Antimicrobial sterol conjugates
WO1999003823A2 (en) * 1997-07-15 1999-01-28 Oridigm Corporation Novel polyamine analogues as therapeutic and diagnostic agents
AU7131698A (en) * 1998-04-21 1999-11-08 Ilex Oncology, Inc. Polyamine transport inhibitors
CA2318004A1 (en) * 1999-09-15 2001-03-15 Oridigm Corporation Novel polyamine analogues as therapeutic and diagnostic agents

Similar Documents

Publication Publication Date Title
JP2004509845A5 (enExample)
JP2005516967A5 (enExample)
CA2442885A1 (en) Sulphones which modulate the action of gamma secretase
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
JP2005538035A5 (enExample)
WO2001072721A3 (en) Synergistic methods and compositions for treating cancer
JP2004531517A5 (enExample)
EA022459B1 (ru) Производные транилципромина в качестве ингибиторов гистон деметилаз lsd1 и/или lsd2
WO2005056524A3 (en) Therapeutic agents useful for treating pain
JP2004534850A5 (enExample)
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
CY1109037T1 (el) Πιπεραζινες χρησιμες για θεραπεια πονου
RU2012133522A (ru) Новое применение соединений ил-1 бета
JP2007520452A5 (enExample)
WO2002089782A3 (en) Dioxanes and uses thereof
JP2005533766A5 (enExample)
CA2154663C (en) Polyamine derivatives as radioprotective agents
RU2004110041A (ru) Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика
SK287908B6 (sk) A pharmaceutical combinations comprising combretastatin and an anticancer agent
JPWO2021074622A5 (enExample)
TWI351950B (en) Use of (halobenzyloxy) benzylamino-propanamides fo
EA200501518A1 (ru) Применение соединений для профилактики лекарственно-индуцированной клеточной токсичности
RU2003134629A (ru) Соединения цефема
JP2008531585A5 (enExample)
JP2005527479A5 (enExample)